واکاوی مفهوم و ارائه مدل مفهومی باختاستراتژیک جهت مهار بحران بیماریهای همهگیر (مورد مطالعه: کووید-19)
محورهای موضوعی : مدیریت صنعتیافروز امینی هرندی 1 , سید محمد رضا داودی 2 , رضا مداحی 3 , رسول عسگرپور 4
1 - دانشجوی دکتری، گروه مدیریت، واحد نجفآباد، دانشگاه آزاد اسلامی، نجفآباد، ایران
2 - دانشیار، گروه مدیریت صنعتی، واحد دهاقان، دانشگاه آزاد اسلامی، دهاقان، ایران
3 - استادیار، گروه ریاضی، واحد نجفآباد، دانشگاه آزاد اسلامی، نجفآباد، ایران
4 - گروه مدیریت، واحد نجف آباد، دانشگاه آزاد اسلامی، نجف آباد، ایران
کلید واژه: Strategic Loss, Crisis Containment, Epidemics, COVID-19,
چکیده مقاله :
در پژوهش حاضر، مدل مفهومی باختاستراتژیک از طریق توسعهی مدل DMDU ارائه شدهاست. محققان در این پژوهش سعی داشتهاند که مدل ارائه شده، در حالی که مزایای دیگر استراتژیها را دارا بوده، متعادلتر و قابلیت استفاده در کشورها و مناطق مختلف را داشته باشد. همچنین، مطلوبیت اکثریت جامعه را با صرف هزینه و تلفات کمتر، به حداکثر رساند. روش پژوهش حاضر، توصیفی _ تحلیلی و روش گردآورى دادهها، به روش كتابخانهاى و اسنادى میباشد. شيوه تجزيه و تحليل دادهها نیز از نوع كيفى مىباشد. در این راستا، ضمن بررسی رایجترین استراتژیها جهت مهار بحران بیماریهای همهگیر و درنظرگرفتن مزایا و معایب و کارکردهایشان، به واکاوی مفهوم باختاستراتژیک پرداخته شده و با دیگر استراتژیها نیز قیاس شدهاست. همچنین، با توجه به اینکه برخی از مهمترین درسهای مهار کووید-19 در مورد مدیریت بیماریهای همهگیر آینده است، طبق یافتههای پژوهش؛ باختاستراتژیک، احتمالاً استراتژی ارجح برای پاسخ به بیماریهای عفونی نوظهور با پتانسیل همهگیری و هر چیزی بیش از شدت متوسط، میباشد. از این رو، پیشنهاد میگردد که تصمیمگیرندگان و سیاستمداران جهت عبور از بحران بیماریهای همهگیر با حداقل آسیبپذیری، از نتایج این پژوهش استفاده کنند.
Outbreaks of epidemics have been both catastrophic and manageable. In addressing the crisis posed by epidemic diseases such as COVID-19, non-pharmacological interventions are often the primary and most prioritized measures available. This study presents a conceptual model of strategic loss through the development of the Decision-Making under Deep Uncertainty (DMDU) model. The researchers aimed to create a model that, while incorporating the advantages of existing strategies, is more balanced and applicable across different countries and regions. Furthermore, the model seeks to maximize societal utility by minimizing both costs and casualties.The research employs a descriptive-analytical method, with data collected through library and document reviews. Qualitative analysis is used to assess the data. In this context, the study examines the most prevalent strategies for containing epidemic crises, evaluating their advantages, disadvantages, and effectiveness. The concept of strategic loss is analyzed and compared to other strategies. Importantly, the findings suggest that some of the key lessons learned from managing COVID-19 pertain to the management of future epidemics. According to the research, a strategy of defeat may be the preferred approach for responding to emerging infectious diseases with pandemic potential and moderate to high severity. Thus, it is recommended that decision-makers and policymakers utilize the results of this research to effectively navigate the crisis of epidemic diseases while minimizing vulnerability.
1. Freedman L. Strategy for a Pandemic: The UK and COVID-19. Survival (Lond). 2020;62(3):25-76. doi:10.1080/00396338.2020.1763610
2. Takes I. Mitigating the COVID economic crisis: act fast and do whatever. Published online 2020.
3. Hasanat MW, Hoque A, Shikha FA, Anwar M, Hamid ABA, Tat HH. The impact of coronavirus (COVID-19) on e-business in Malaysia. Asian J Multidiscip Stud. 2020;3(1):85-90.
4. Reeves M, Lang N, Carlsson-Szlezak P. Lead your business through the coronavirus crisis. Harv Bus Rev. 2020;27:2-7.
5. Syrett M, Devine M. Managing Uncertainty: Strategies for Surviving and Thriving in Turbulent Times. John Wiley \& Sons; 2012.
6. Alvarez FE, Argente D, Lippi F. A Simple Planning Problem for Covid-19 Lockdown.; 2020.
7. Bolisani E, Bratianu C, Bolisani E, Bratianu C. The Emergence of Knowledge Management. Springer; 2018.
8. Bratianu C, Bejinaru R. COVID-19 induced emergent knowledge strategies. Knowl Process Manag. 2021;28(1):11-17. doi:10.1002/kpm.1656
9. Taleb NN. The Black Swan. The Impact of the Highly Improbable. New York: Random House, 2007. Reviewed by James Iain Gow Université de Montréal, Canada.
10. Amini Harandi A, Asgarpour R. Application of strategic loss in the Corona virus crisis. J Strateg Stud Public Policy. 2020;10(35):362-379.
11. Marchau VAWJ, Walker WE, Bloemen PJTM, Popper SW. Decision Making under Deep Uncertainty: From Theory to Practice. Springer Nature; 2019.
12. Knight FH. Risk, Uncertainty and Profit. Vol 31. Houghton Mifflin; 1921.
13. Argote L. Input uncertainty and organizational coordination in hospital emergency units. Adm Sci Q. Published online 1982:420-434.
14. McKibbin W, Triggs A. Modelling the G20. Centre for Applied Macroeconomic Analysis. Aust Natl Univ. Published online 2018.
15. McKibbin W, Fernando R. The global macroeconomic impacts of COVID-19: Seven scenarios. Asian Econ Pap. 2021;20(2):1-30.
16. De Meyer A, Loch CH, Pich MT. Managing project uncertainty: from variation to chaos. MIT Sloan Manag Rev. 2002;43(2):60.
17. Zack MH. Developing a knowledge strategy. Calif Manage Rev. 1999;41(3):125-145.
18. Alexander A, De Smet A, Weiss L. Decision making in uncertain times. McKinsey Digit. 2020;(March):6.
19. Regalado A. What is herd immunity and can it stop the coronavirus. MIT Technol Rev https//www Technol com/2020/03/17/905244/what-isherd-immunity-and-can-it-stop-the-coronavirus/ Eri{\c{s}}im Tarihi. 2020;9:2021.
20. World Health Organization (2020, others. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Published online 2020.
21. Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020;78(April):185-193. doi:10.1016/j.ijsu.2020.04.018
22. Gostin LO, Wiley LF. Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions. Jama. 2020;323(21):2137-2138.
23. Jamaludin S, Azmir NA, Mohamad Ayob AF, Zainal N. COVID-19 exit strategy: Transitioning towards a new normal. Ann Med Surg. 2020;59(September):165-170. doi:10.1016/j.amsu.2020.09.046
24. Khari D, Sharma V, Agarwal N. Effect of Pandemic COVID-19 on Economic Crisis and Health Issues Globally. Cosm J Eng …. 2020;(July). doi:10.46360/globus.xxxxxx
25. Madani K. Hydropower licensing and climate change: Insights from cooperative game theory. Adv Water Resour. 2011;34(2):174-183. doi:10.1016/j.advwatres.2010.10.003
26. Baker MG, Wilson N, Blakely T. Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases. BMJ. 2020;371(fig 1):1-4. doi:10.1136/bmj.m4907
27. Baker MG, Wilson N, Anglemyer A. Successful elimination of Covid-19 transmission in New Zealand. N Engl J Med. 2020;383(8):e56.
28. Summers J, Cheng HY, Lin HH, et al. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health West Pac. 2020; 4: 100044. Published online 2020.
29. Giesecke J. The invisible pandemic. Lancet. 2020;395(10238):e98.
30. Goodman RA, Foster KL, Trowbridge FL, Figueroa JP, Organization WH, others. Global Disease Elimination and Eradication as Public Health Strategies: Proceedings of a Conference, Atlanta, Georgia, USA, 23-25 February 1996. World Health Organization; 1998.
31. Tutunchian M, Khoshhal J. Crisis Management and Reducing the Risk of Coronavirus Infection (with Emphasis on Iran’s Capabilities) Mehri. 2020;(3):227-239.
32. Thompson RN, Hollingsworth TD, Isham V, et al. Key questions for modelling COVID-19 exit strategies. Proc R Soc B Biol Sci. 2020;287(1932). doi:10.1098/rspb.2020.1405
33. Iqbal MR, Chaudhuri A. COVID-19: Results of a national survey of United Kingdom healthcare professionals’ perceptions of current management strategy--A cross-sectional questionnaire study. Int J Surg. 2020;79:156-161.
34. Rogers A. The Asian countries that beat COVID-19 have to do it again. Availabe online https//www wired com/story/the-asian-countries-that-beat-covid-19-have-to-do-it-again/(accessed 3 July). Published online 2020.
35. Baker MG, Kvalsvig A, Verrall AJ, Wellington N. New Zealand’s COVID-19 elimination strategy. Med J Aust. 2020;213(5):198-200.
36. of Eight Australia G. COVID-19: roadmap to recovery: a report for the nation. Gr Eight Ltd. Published online 2020.
37. Foss NJ. Behavioral Strategy and the COVID-19 Disruption. J Manage. 2020;46(8):1322-1329. doi:10.1177/0149206320945015
38. Munblit D, Simpson F, Mabbitt J, Dunn-Galvin A, Semple C, Warner JO. Legacy of COVID-19 infection in children: long-COVID will have a lifelong health/economic impact. Arch Dis Child. 2022;107(3):e2--e2.
39. Torjesen I. Covid-19 vaccine shortages: what is the cause and what are the implications? Published online 2021.
40. Baker M. In Alaskaʼs Covid Crisis, Doctors Must Decide Who Lives and Who Dies. Published online 2021.
41. Lindström M. The COVID-19 pandemic and the Swedish strategy: Epidemiology and postmodernism. SSM - Popul Heal. 2020;11(June). doi:10.1016/j.ssmph.2020.100643
42. Habib H. Has Sweden’s controversial covid-19 strategy been successful? BMJ. 2020;369. doi:10.1136/bmj.m2376
43. Bratianu C, others. Developing strategic thinking in business education. Manag Dyn Knowl Econ. 2015;3(3):409-429.
44. Soriano SG, Vutskits L, Jevtovic-Todorovic V, et al. Thinking, fast and slow: highlights from the 2016 BJA seminar on anaesthetic neurotoxicity and neuroplasticity. BJA Br J Anaesth. 2017;119(3):443-447.